Amy Zhang
Rheumatology · Newark, DENPI 1861811952
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.0%), consulting fees and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Johnson & Johnson at 54.9% of the total. Reporting peaked in 2024 at $3,110 and has fallen 85.4% since, to $455 in 2025.
Across 199 payments — averaging $38.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Amgen$477
- AbbVie$440
- Novartis$400
- AstraZeneca$360
- Lilly USA, LLC$282
- plus $1K from 18 others
What the payments were for
- Consulting fees$3,49046%
- Food & beverage$4,02153%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 36 | $4,161 |
| Amgen | 18 | $477 |
| AbbVie | 21 | $440 |
| Novartis | 20 | $400 |
| AstraZeneca(2 entities) | 22 | $360 |
| Lilly USA, LLC | 11 | $282 |
| Genentech USA, Inc. | 14 | $219 |
| UCB, Inc. | 9 | $186 |
| GSK | 10 | $177 |
| Mallinckrodt Hospital Products Inc. | 4 | $102 |
| ANI Pharmaceuticals, Inc. | 5 | $101 |
| Cardinal Health 110 LLC | 1 | $100 |
| Aurinia Pharma U.S., Inc. | 6 | $92 |
| Pfizer | 5 | $90 |
| Janssen Scientific Affairs, LLC | 1 | $86 |
| Boehringer Ingelheim | 3 | $65 |
| Sandoz | 3 | $58 |
| Scilex Pharmaceuticals Inc. | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Sanofi | 2 | $28 |
| Radius Health, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$3,617
- SIMPONI ARIA$1,500
- Prolia$112
How this compares
Too few rheumatology providers in Delawareto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrenciaAbatacept | 14 | $92,401 |
| Hydroxychloroquine Sulfate | 72 | $4,198 |
| MethotrexateMethotrexate Sodium | 72 | $2,576 |
| Colchicine | 24 | $1,943 |
| Prednisone | 87 | $1,261 |
| Leflunomide | 27 | $642 |
| Allopurinol | 20 | $307 |
| Folic Acid | 18 | $302 |
| Methylprednisolone | 22 | $218 |
| Alendronate Sodium | 22 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Orencia | $42 | $92,40114 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $46 | $1,94324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few rheumatology providers in Delawareon file to place this against a meaningful peer group, so we don't.
Other rheumatology in Newark
- Pietro RoccaNewark$2K
- Devanshu VermaNewark$614
- Douglas LieneschNewark$469
- Sheerin JavedNewark$42
- Jose PandoLewes$93K
- Lourdes AponteLewes$20K
- Jinsong ZhangDover$11K
- Philip SchwartzWilmington$10K
- Ivonne HerreraSeaford$9K
- Surjeet DheerDover$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.